AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,452.00p
   
  • Change Today:
    -140.00p
  • 52 Week High: 14,148.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.91m
  • Volume: 121,903
  • Market Cap: £208,628m
  • RiskGrade: 123
  • Beta: 1.27

Latest Deals

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 746,354 £100,399,540
Aradhana Sarin 93,804 £12,618,514
Marcus Wallenberg 60,028 £8,074,967
Philip A J Broadley 19,495 £2,622,467
Michel Demare 10,000 £1,345,200
Tony Mok 3,500 £470,820
Sheri McCoy 1,736 £233,527
Karen Knudsen 1,405 £189,001
Diana Layfield 1,400 £188,328
Euan Ashley 1,150 £154,698
Nazneen Rahman 720 £96,854
Anna Manz 487 £65,511

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £13,571,074,548
Oddo Meriten Asset Management SA 100,885,181 £13,571,074,548
The Capital Group Companies, Inc. 77,125,348 £10,374,901,813
Wellington Management Company LLP 65,118,411 £8,759,728,648
Investor AB 51,587,810 £6,939,592,201

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,452.00p
Change Today -140.00p
% Change -1.03 %
52 Week High 14,148.00p
52 Week Low 9,667.00p
Volume 121,903
Shares Issued 1,550.91m
Market Cap £208,628m
Beta 1.27
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 05-Jan-2026

Time Volume / Share Price
09:00 17 @ 13,452.00p
09:00 37 @ 13,452.00p
09:00 19 @ 13,452.00p
09:00 172 @ 13,452.00p
09:00 50 @ 13,452.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page